$1.17
2.63% today
Nasdaq, Feb 28, 05:46 pm CET
ISIN
CA68620P1018
Symbol
OGI
Sector
Industry

OrganiGram Holdings Inc Stock price

$1.14
-0.39 25.49% 1M
-0.69 37.70% 6M
-0.47 29.19% YTD
-1.02 47.22% 1Y
-4.82 80.87% 3Y
-7.74 87.16% 5Y
-0.52 31.49% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.02 1.72%
ISIN
CA68620P1018
Symbol
OGI
Sector
Industry

Key metrics

Market capitalization $143.89m
Enterprise Value $101.31m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.84
P/S ratio (TTM) P/S ratio 1.19
P/B ratio (TTM) P/B ratio 0.64
Revenue growth (TTM) Revenue growth 5.85%
Revenue (TTM) Revenue $121.24m
EBIT (operating result TTM) EBIT $-59.45m
Free Cash Flow (TTM) Free Cash Flow $-6.50m
Cash position $49.49m
EPS (TTM) EPS $-0.38
P/E forward negative
P/S forward 0.87
EV/Sales forward 0.61
Short interest 5.92%
Show more

Is OrganiGram Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

OrganiGram Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a OrganiGram Holdings Inc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a OrganiGram Holdings Inc forecast:

Buy
80%
Hold
20%

Financial data from OrganiGram Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
121 121
6% 6%
100%
- Direct Costs 124 124
12% 12%
103%
-3.13 -3.13
88% 88%
-3%
- Selling and Administrative Expenses 40 40
5% 5%
33%
- Research and Development Expense 6.65 6.65
41% 41%
5%
-50 -50
35% 35%
-41%
- Depreciation and Amortization 9.22 9.22
44% 44%
8%
EBIT (Operating Income) EBIT -59 -59
36% 36%
-49%
Net Profit -38 -38
81% 81%
-32%

In millions USD.

Don't miss a Thing! We will send you all news about OrganiGram Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OrganiGram Holdings Inc Stock News

Positive
Seeking Alpha
5 days ago
Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales.
Positive
Seeking Alpha
5 days ago
Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company reported a 17% revenue growth in Q1 FY24, driven by international expansion and the Motif Labs acquisition, despite missing expectations. Organigram's balance sheet is robust with C$46.8 million in cas...
Neutral
Seeking Alpha
17 days ago
Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
More OrganiGram Holdings Inc News

Company Profile

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Head office Canada
CEO Beena Goldenberg
Employees 898
Founded 2010
Website www.organigram.ca

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today